Press Release

Total 8
Number Title Date
7
Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA
donghee.im donghee.im | 2024.07.31 | Votes 0 | Views 299
2024.07.31
Re:Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA
Myron Kirkby Myron Kirkby | 2025.05.24 | Votes 0 | Views 11
Myron Kirkby
Myron Kirkby 		2025.05.24 0 11
6
Prestige Biologics hires former Lonza official as new director
IPR IPR | 2024.05.23 | Votes 0 | Views 516
2024.05.23
5
Prestige Biologics achieves ISO certifications, enhancing its global position as a leading ESG CDMO company
IPR IPR | 2024.01.30 | Votes 0 | Views 745
2024.01.30
4
Prestige Biologics signed 5-year CMO service agreement with Celltrion
IPR IPR | 2024.01.17 | Votes 0 | Views 798
2024.01.17
3
Prestige Biologics enters into MOU with Aurigene Pharmaceutical Services Limited to explore collaboration in CDMO market
IPR IPR | 2023.09.22 | Votes 0 | Views 774
2023.09.22
2
Prestige Biopharma and Imagion Biosystems sign an MOU, developing early pancreatic cancer diagnosis platform
IPR IPR | 2023.08.11 | Votes 0 | Views 715
2023.08.11
1
Prestige Biopharma joins CancerX as a member
IPR IPR | 2023.07.18 | Votes 0 | Views 773
2023.07.18
New